Affinage

NPTX2

Neuronal pentraxin-2 · UniProt P47972

Length
431 aa
Mass
47.0 kDa
Annotated
2026-06-10
46 papers in source corpus 15 papers cited in narrative 15 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/8 claims corpus-supported (88%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

NPTX2 is a secreted neuronal pentraxin and activity-dependent immediate early gene expressed presynaptically by excitatory pyramidal neurons that shapes inhibitory circuit control of network excitability (PMID:8530029, PMID:28440221). It strengthens excitatory synapses onto fast-spiking parvalbumin (PV) interneurons by controlling AMPA receptor clustering: loss of NPTX2 reduces GluA4 expression, disrupts network rhythmicity, and increases pyramidal neuron excitability (PMID:28440221), while its pentraxin domain recruits GluA1-containing AMPA receptors to enhance excitatory transmission during memory processes (PMID:31836174). This synaptic action requires activity-dependent exocytosis and dynamic synaptic shedding, and is needed for PV interneurons to adaptively respond to behavioral stress (PMID:34818031). Through enhanced feedforward and perisomatic inhibition, NPTX2 supports spatial memory and memory precision, with overexpression rescuing impairments in aged animals [PMID:40057261, PMID:bio_10.1101_2025.05.19.654996] and regulating hippocampus-dependent anxiety behavior (PMID:29844474). NPTX2 also binds complement C1q to restrain C1q-dependent microglial engulfment of synapses, and neuronal NPTX2 overexpression limits complement-mediated synapse loss (PMID:36989373). Its protein levels are set post-transcriptionally by TDP-43 binding to the NPTX2 3' UTR; loss of nuclear TDP-43 causes neurotoxic NPTX2 misaccumulation, and correcting this partially rescues neurodegeneration (PMID:38355792). NPTX2 KO also disrupts sleep architecture and circadian rhythms independently of orexin (PMID:37808783). In non-neural cancers NPTX2 acts context-dependently, physically engaging FZD6 to activate Wnt/β-catenin signaling (PMID:30833544), METTL3 to drive m6A modification of SNAIL (PMID:36638907), and modulating IL6-JAK2/STAT3 (PMID:33768003) or p53 (PMID:33896384) pathways, with its expression frequently silenced by promoter hypermethylation (PMID:21161403, PMID:33896384).

Mechanistic history

Synthesis pass · year-by-year structured walk · 12 steps
  1. 1995 Medium

    Established the molecular identity of NPTX2 as a secreted pentraxin-family glycoprotein, setting the stage for studying it as an extracellular effector.

    Evidence cDNA cloning, genomic sequencing, and Northern blot across multiple tissues

    PMID:8530029

    Open questions at the time
    • No functional or interaction partners identified
    • Brain-specific role not yet addressed
  2. 2017 High

    Defined NPTX2 as an activity-dependent presynaptic factor that controls excitatory drive onto PV interneurons via GluA4, answering how it tunes network excitability.

    Evidence Nptx2 knockout mice with electrophysiology, immunohistochemistry, and human postmortem cortex

    PMID:28440221

    Open questions at the time
    • Receptor/binding partner mediating GluA4 clustering not defined
    • Mechanism of activity-dependent regulation unresolved
  3. 2018 High

    Localized NPTX2 function to the adult hippocampus in regulating stress-related anxiety and neurogenesis, distinguishing region-specific roles.

    Evidence Region-specific conditional Nptx2 knockout/overexpression, anxiety behavior, glucocorticoid target gene and neurogenesis readouts

    PMID:29844474

    Open questions at the time
    • Molecular link between NPTX2 and glucocorticoid signaling unclear
    • Cell-autonomous vs circuit contribution not separated
  4. 2019 High

    Showed the pentraxin domain recruits GluA1-AMPA receptors to remodel synapses during memory retrieval, mechanistically linking NPTX2 to synaptic plasticity.

    Evidence Translational profiling, electrophysiology, activity-dependent marking, and GluA1 tail dominant-negative in dorsal hippocampus

    PMID:31836174

    Open questions at the time
    • Direct NPTX2-GluA1 binding interface not resolved
    • Generalizability beyond cocaine extinction memory untested
  5. 2019 Medium

    Identified a non-neural oncogenic mode in which NPTX2 binds FZD6 to drive Wnt/β-catenin signaling and colorectal cancer growth.

    Evidence Co-IP, FZD6 siRNA epistasis, proliferation/invasion assays, xenograft, β-catenin target Western blots

    PMID:30833544

    Open questions at the time
    • Single Co-IP without reciprocal/structural validation
    • Reconciliation with tumor-suppressive roles in other cancers not addressed
  6. 2021 High

    Demonstrated that NPTX2 function depends on activity-driven exocytosis and synaptic shedding and is required for PV interneurons to respond to behavioral stress.

    Evidence Transgenic loss-of-function and plasticity-disrupting mutant mice, trafficking assays, behavioral stress paradigms

    PMID:34818031

    Open questions at the time
    • Identity of shedding protease/machinery unknown
    • Molecular determinants of trafficking not fully mapped
  7. 2021 Medium

    Extended the cancer repertoire by linking NPTX2 to p53/p21/PTEN and IL6-JAK2/STAT3 pathways, showing context-dependent signaling outputs.

    Evidence Gain/loss-of-function in gastric and ovarian cancer cells, pathway Western blots, luciferase reporter, HIF-1 regulation, xenografts

    PMID:33768003 PMID:33896384

    Open questions at the time
    • Direct molecular targets of NPTX2 in these pathways unidentified
    • Whether effects require secretion or receptor engagement unknown
  8. 2023 High

    Revealed NPTX2 as a C1q-binding restraint on complement-mediated microglial synapse elimination, providing a mechanism for synapse protection.

    Evidence NPTX2-C1q Co-IP, Nptx2 KO, AAV overexpression rescue in TauP301S mice, complement and engulfment assays, human FTD CSF

    PMID:36989373

    Open questions at the time
    • Structural basis of NPTX2-C1q inhibition not defined
    • Quantitative balance between synaptic and complement-regulatory roles unclear
  9. 2023 Medium

    Implicated NPTX2 in sleep and circadian regulation independent of orexin, broadening its physiological scope.

    Evidence Nptx2 KO mice with EEG/EMG sleep recording, circadian monitoring, orexin immunostaining (preprint)

    PMID:37808783

    Open questions at the time
    • Preprint, not peer-reviewed
    • Circuit mediating circadian/sleep effects not identified
  10. 2023 Medium

    Uncovered a cancer mechanism in which NPTX2 binds METTL3 to enhance m6A modification of SNAIL and drive EMT.

    Evidence NPTX2-METTL3 Co-IP, lentiviral overexpression/knockdown, m6A assays, METTL3 KD epistasis, xenograft

    PMID:36638907

    Open questions at the time
    • How a secreted pentraxin engages nuclear METTL3 unresolved
    • Single-lab finding without reciprocal validation
  11. 2024 High

    Placed NPTX2 downstream of TDP-43 through 3' UTR binding, explaining how TDP-43 pathology drives neurotoxic NPTX2 misaccumulation.

    Evidence iPSC-derived neural networks, single-cell transcriptomics, TDP-43 aggregation, NPTX2 rescue/toxicity, ALS/FTLD patient tissue

    PMID:38355792

    Open questions at the time
    • Mechanism by which excess NPTX2 causes toxicity not fully defined
    • Therapeutic window for NPTX2 correction untested
  12. 2025 High

    Showed that NPTX2-mediated recruitment of fast-spiking interneurons enhances feedforward and perisomatic inhibition to maintain memory proficiency and precision, with overexpression rescuing aged-animal deficits.

    Evidence AAV overexpression in LEC and engram cells, in vivo electrophysiology, fear/spatial memory tests, chemogenetic PV interneuron epistasis (one preprint)

    PMID:40057261 PMID:bio_10.1101_2025.05.19.654996

    Open questions at the time
    • One study is a preprint
    • Durability of overexpression rescue not established

Open questions

Synthesis pass · forward-looking unresolved questions
  • How a single secreted pentraxin reconciles its synaptic AMPAR-clustering and C1q-inhibitory roles in neurons with diverse intracellular cancer signaling outputs remains unresolved.
  • No structural model of NPTX2 bound to AMPAR, C1q, or FZD6
  • Mechanism by which a secreted protein influences nuclear/cytoplasmic cancer pathways unexplained
  • No unifying biochemical activity defined across neural and non-neural contexts

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060089 molecular transducer activity 3 GO:0098772 molecular function regulator activity 3
Localization
GO:0005576 extracellular region 3 GO:0005886 plasma membrane 2

Evidence

Reading pass · 15 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1995 NPTX2 (neuronal pentraxin II) was identified as a secreted member of the pentraxin family with potential N-linked glycosylation sites, expressed in brain, testis, pancreas, liver, heart, and skeletal muscle. The human gene is 11 kb, contains four introns, and is localized to chromosome 7q21.3-q22.1. cDNA cloning, Northern blot analysis, genomic sequencing Genomics Medium 8530029
2017 NPTX2 is an activity-dependent immediate early gene expressed presynaptically by pyramidal neurons that regulates excitatory synapses onto parvalbumin (PV) interneurons by controlling AMPA receptor subunit GluA4 expression. In Nptx2-/- mice, GluA4 expression is reduced, network rhythmicity is disrupted, and pyramidal neuron excitability is increased. Nptx2 knockout mouse model, electrophysiology, immunohistochemistry, postmortem human cortex analysis eLife High 28440221
2021 NPTX2 function requires activity-dependent exocytosis and dynamic shedding at synapses. Behavior-linked NPTX2 trafficking is abolished by mutations that disrupt select activity-dependent plasticity mechanisms of excitatory neurons. NPTX2 loss of function results in failure of parvalbumin interneurons to adaptively respond to behavioral stress. Transgenic mouse models with Nptx2 loss of function, activity-dependent trafficking assays, behavioral stress paradigms Science advances High 34818031
2023 NPTX2 binds complement C1q and thereby regulates complement activity in the brain. Nptx2-deficient mice show increased complement activity, C1q-dependent microglial synapse engulfment, and loss of excitatory synapses. AAV-mediated neuronal overexpression of Nptx2 was sufficient to restrain complement activity and ameliorate microglia-mediated synapse loss. Co-immunoprecipitation (NPTX2-C1q interaction), Nptx2 knockout mouse, AAV overexpression in aged TauP301S mice, complement activity assays, synapse engulfment quantification, CSF analysis of human FTD samples Science translational medicine High 36989373
2024 TDP-43 binds the 3' UTR of NPTX2 mRNA to control NPTX2 protein levels. Loss of nuclear TDP-43 function leads to NPTX2 misaccumulation/overexpression, which causes neurotoxicity. Correcting NPTX2 misregulation partially rescues neurons from TDP-43-induced neurodegeneration. iPSC-derived neural networks (iNets), single-cell transcriptomics, TDP-43 overexpression causing aggregation, NPTX2 overexpression rescue/toxicity experiments, patient tissue validation (ALS/FTLD) Nature High 38355792
2019 NPTX2 interacts physically with frizzled class receptor 6 (FZD6) to promote β-catenin nuclear translocation, activating the Wnt/β-catenin signaling pathway and driving colorectal cancer cell proliferation and metastasis. Knockdown of FZD6 almost completely reversed NPTX2's proliferative effects. Co-immunoprecipitation (NPTX2-FZD6 interaction), siRNA knockdown of FZD6, in vitro proliferation/invasion assays, in vivo xenograft, Western blot of β-catenin targets Cell death & disease Medium 30833544
2019 In dorsal hippocampus, retrieval-driven upregulation of NPTX2 recruits GluA1-AMPA receptors via its pentraxin (PTX) domain, enhancing excitatory synaptic transmission and facilitating extinction of cocaine-associated context memory. Overexpressing the carboxyl cytoplasmic tail of GluA1 prevented NPTX2-mediated synaptic remodeling. Ribosomal tagging translational profiling, electrophysiology, neuronal tracing, doxycycline-dependent activity marking (DRAM system), Nptx2 manipulation in dorsal hippocampus, GluA1 tail overexpression Biological psychiatry High 31836174
2018 NPTX2 expression in the adult hippocampus regulates anxiety behavior and hippocampal cell proliferation. Hippocampus-specific (but not amygdala-specific) Nptx2 knockout increased anxiety and altered glucocorticoid receptor target gene expression after acute stress. Overexpression of Nptx2 in hippocampus alleviated stress-induced anxious behaviors. Region-specific conditional Nptx2 knockout and overexpression mouse models, behavioral anxiety assays, gene expression analysis of glucocorticoid receptor targets, adult neurogenesis quantification Neuropsychopharmacology High 29844474
2010 Ectopic NPTX2 expression in pancreatic cancer cells (PANC-1) promotes G0-G1 arrest and apoptosis (upregulating Bax and downregulating Cyclin D1), and reduces cell proliferation, migration, and invasion. Low endogenous NPTX2 expression in pancreatic cancer cells correlates with promoter hypermethylation, which is reversed by the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine. Stable NPTX2 cDNA transfection in PANC-1 cells, cell cycle analysis, apoptosis assays, methylation-specific PCR, 5-aza-dC treatment, Western blot Molecular biology reports Medium 21161403
2021 NPTX2 promotes gastric cancer cell proliferation and inhibits apoptosis and cell cycle arrest by activating the p53 signaling pathway. NPTX2 overexpression enhanced protein expression of p53, p21, and PTEN. NPTX2 promoter hypermethylation causes its downregulation in gastric cancer cells. Western blot, colony formation, CCK-8, flow cytometry, methylation-specific PCR Bioengineered Medium 33896384
2021 NPTX2 overexpression promotes proliferation, invasion, migration, and tumorigenesis of epithelial ovarian cancer cells via activation of the IL6-JAK2/STAT3 signaling pathway. Hypoxia-inducible factor 1 (HIF-1) promotes NPTX2 transcription under hypoxic conditions. NPTX2 knockdown abolished hypoxia-induced malignant phenotypes. Lentiviral overexpression/knockdown in EOC cell lines, MTS assay, EdU assay, transwell assay, luciferase reporter assay, xenograft experiment, Western blot Frontiers in oncology Medium 33768003
2023 NPTX2 interacts with METTL3, increases METTL3 expression, and promotes METTL3-mediated N6-methyladenosine (m6A) modification of SNAIL mRNA, thereby facilitating epithelial-mesenchymal transition in cutaneous squamous cell carcinoma. METTL3 knockdown and m6A inhibition reversed NPTX2 overexpression effects. Co-immunoprecipitation (NPTX2-METTL3 interaction), lentiviral overexpression/knockdown, Western blot, m6A assays, xenograft experiment The Journal of investigative dermatology Medium 36638907
2025 NPTX2 overexpression in lateral entorhinal cortex (LEC) neurons stabilizes excitatory inputs onto fast-spiking inhibitory interneurons (FS-INs), enhancing feedforward inhibition of dentate gyrus granule cells, and improves spatial memory in aged learning-impaired rats. This demonstrates that NPTX2-mediated recruitment of FS-INs is required for maintaining proficient memory. AAV-mediated Nptx2 overexpression in LEC, in vivo electrophysiology (feedforward inhibition measurement), spatial memory behavioral testing in aged rats Progress in neurobiology High 40057261
2023 NPTX2 KO mice exhibit disrupted circadian onset time, increased activity during the sleep phase, sleep fragmentation, altered power across EEG frequency bands in wake/NREM/REM states, and diminished sleep spindles. These sleep and circadian rhythm disruptions occur despite intact orexin expression, establishing NPTX2 as an independent effector of sleep/circadian regulation. Nptx2 KO mice, EEG/EMG sleep recording, circadian activity monitoring, brain orexin immunostaining bioRxivpreprint Medium 37808783
2025 In hippocampal dentate gyrus engram cells, NPTX2 facilitates perisomatic inhibition of Npas4+ ensemble neurons by parvalbumin+ interneurons, preventing fear memory overgeneralization. NPTX2 depletion in Npas4+ engram cells causes memory imprecision, and overexpression of the AMPAR-binding domain of NPTX2 in Npas4+ ensembles rescued memory imprecision in aged mice. Engram-specific NPTX2 depletion and overexpression (viral strategies), behavioral fear memory tests, chemogenetic activation of PV+ interneurons as epistasis control bioRxivpreprint Medium bio_10.1101_2025.05.19.654996

Source papers

Stage 0 corpus · 46 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2017 NPTX2 and cognitive dysfunction in Alzheimer's Disease. eLife 213 28440221
2023 The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Science translational medicine 115 36989373
1995 Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization. Genomics 92 8530029
2019 NPTX2 promotes colorectal cancer growth and liver metastasis by the activation of the canonical Wnt/β-catenin pathway via FZD6. Cell death & disease 55 30833544
2024 A model of human neural networks reveals NPTX2 pathology in ALS and FTLD. Nature 47 38355792
2020 HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2 via miR-221-3p binding. Aging 46 32396526
2023 NPTX2 in Cerebrospinal Fluid Predicts the Progression From Normal Cognition to Mild Cognitive Impairment. Annals of neurology 43 37345460
2012 The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. Pancreas 39 21778928
2021 A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function. Science advances 35 34818031
2019 Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults. Frontiers in aging neuroscience 35 31231205
2020 Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome. Molecular neurodegeneration 33 32807227
2020 Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. Cells 30 33383752
2013 Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma. Journal of neuro-oncology 30 23624749
2019 Retrieval-Driven Hippocampal NPTX2 Plasticity Facilitates the Extinction of Cocaine-Associated Context Memory. Biological psychiatry 29 31836174
2018 NPTX2 is a key component in the regulation of anxiety. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 27 29844474
2010 The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro. Molecular biology reports 26 21161403
2020 Association between serum NPTX2 and cognitive function in patients with vascular dementia. Brain and behavior 25 32748547
2007 Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer. Pancreas 23 17895837
2021 Neuronal pentraxin II (NPTX2) hypermethylation promotes cell proliferation but inhibits cell cycle arrest and apoptosis in gastric cancer cells by suppressing the p53 signaling pathway. Bioengineered 18 33896384
2013 NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms. The American journal of the medical sciences 18 23360791
2012 Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers. Digestive diseases and sciences 18 22806544
2021 Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia. Frontiers in oncology 13 33768003
2021 Silencing circular RNA circ_0054537 and upregulating microRNA-640 suppress malignant progression of renal cell carcinoma via regulating neuronal pentraxin-2 (NPTX2). Bioengineered 12 34565284
2015 NPTX2 is associated with neoadjuvant therapy response in rectal cancer. The Journal of surgical research 12 27083956
2019 MicroRNA-96 is a potential tumor repressor by inhibiting NPTX2 in renal cell carcinoma. Journal of cellular biochemistry 10 31498486
2024 Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis. Frontiers in neurology 9 38566855
2024 miR-133b as a potential regulator of a synaptic NPTX2 protein in Alzheimer's disease. Annals of clinical and translational neurology 8 39289904
2022 Promoter Methylation-Mediated NPTX2 Silencing Promotes Tumor Growth in Human Prostate Cancer. Journal of Cancer 8 35069913
2023 NPTX2 Promotes Epithelial-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma through METTL3-Mediated N6-Methyladenosine Methylation of SNAIL. The Journal of investigative dermatology 7 36638907
2022 miR-1251-5p Overexpression Inhibits Proliferation, Migration, and Immune Escape in Clear Cell Renal Cell Carcinoma by Targeting NPTX2. Journal of oncology 7 35310907
2022 Neuronal pentraxin-2 (NPTX2) serum levels during an acute psychotic episode in patients with schizophrenia. Psychopharmacology 6 35482070
2025 Cognitive resilience in preclinical Alzheimer's disease: Higher NPTX2 and VGF levels are associated with reduced cognitive decline. Neurobiology of aging 5 40945027
2025 NPTX2 transfection improves synaptic E/I balance and performance in learning impaired aged rats. Progress in neurobiology 3 40057261
2025 Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. Alzheimer's & dementia : the journal of the Alzheimer's Association 2 40522075
2025 CSF Levels of NPTX2 Are Associated With Less Brain Atrophy Over Time in Cognitively Unimpaired Individuals. Annals of clinical and translational neurology 2 41063558
2025 Cerebrospinal fluid NPTX2 and [18F]FDG PET track serotonergic vulnerability to neurodegeneration in prodromal Alzheimer's disease. Alzheimer's research & therapy 2 41272913
2025 Transcriptomic and protein analysis of human cortex reveals genes and pathways linked to NPTX2 disruption in Alzheimer's disease. bioRxiv : the preprint server for biology 2 41279079
2024 Serum NPTX2 as a Potential Predictive Biomarker for Postoperative Delirium in Patients with Acute Type A Aortic Dissection. Neuropsychiatric disease and treatment 2 38741580
2025 Altered NPTX2 dynamics associated with impaired cognitive aging. bioRxiv : the preprint server for biology 1 41000823
2024 Aberrant DNA Methylation of NPTX2 as an Indicator of Malignant Behavior in Thymic Epithelial Tumors. Cancers 1 38254821
2023 Sleep and circadian rhythm disruption by NPTX2 loss of function. bioRxiv : the preprint server for biology 1 37808783
2020 Determination of epigenetic age through DNA methylation of NPTX2 gene using buccal scrapes: A pilot study. Journal of forensic dental sciences 1 32801587
2026 Cerebrospinal fluid HOMER1 and NPTX2 as candidate signatures in early-stage multiple system atrophy-parkinsonism. Journal of the neurological sciences 0 41780424
2026 NPTX2 accelerates cell cycle progression, activates EMT, and regulates glycolytic metabolic pathways to promote clear cell renal cell carcinoma progression. Biochemical pharmacology 0 41956427
2025 Xixin Decoction May Treat Vascular Dementia by Modulating the NPTX2/C1q/C3 Complement Pathway. Chemistry & biodiversity 0 39737553
2025 Serum Npas-4 and Nptx-2 Levels in Alzheimer's Disease: Potential Biomarkers of Synaptic Dysfunction in a Cross-Sectional Study. Biomolecules 0 40563435

Missed literature

Know a paper Affinage missed for NPTX2? Flag it for the maintainers and the community.

No submissions yet.